Essex Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.4M Buy
23,226
+6
+0% +$6.08K 1.2% 15
2025
Q4
$25M Sell
23,220
-203
-0.9% -$194K 1.42% 11
2025
Q3
$17.9M Sell
23,423
-747
-3% -$556K 1.07% 14
2025
Q2
$18.8M Sell
24,170
-918
-4% -$713K 1.24% 14
2025
Q1
$20.7M Sell
25,088
-941
-4% -$783K 1.49% 11
2024
Q4
$20.1M Sell
26,029
-78
-0.3% -$64.6K 1.42% 13
2024
Q3
$23.7M Sell
26,107
-2,136
-8% -$1.92M 1.71% 9
2024
Q2
$23.9M Buy
28,243
+1,616
+6% +$1.29M 1.77% 6
2024
Q1
$20.7M Buy
26,627
+1,546
+6% +$1.1M 1.91% 7
2023
Q4
$14.6M Sell
25,081
-281
-1% -$164K 1.51% 10
2023
Q3
$13.6M Sell
25,362
-266
-1% -$137K 1.58% 12
2023
Q2
$12M Buy
25,628
+438
+2% +$184K 1.37% 13
2023
Q1
$8.65M Sell
25,190
-466
-2% -$157K 0.91% 20
2022
Q4
$9.38M Buy
25,656
+432
+2% +$153K 0.99% 18
2022
Q3
$8.16M Sell
25,224
-79
-0.3% -$25K 0.97% 19
2022
Q2
$8.2M Buy
25,303
+126
+0.5% +$37.8K 0.91% 22
2022
Q1
$7.21M Buy
25,177
+1,987
+9% +$511K 0.69% 33
2021
Q4
$6.41M Sell
23,190
-849
-4% -$215K 0.63% 38
2021
Q3
$5.55M Sell
24,039
-1,118
-4% -$276K 0.63% 33
2021
Q2
$4.7M Hold
25,157
0.68% 27
2021
Q1
$4.7M Sell
25,157
-605
-2% -$118K 0.84% 25
2020
Q4
$4.35M Buy
25,762
+2,292
+10% +$342K 0.86% 20
2020
Q3
$3.47M Buy
23,470
+2,215
+10% +$343K 0.85% 28
2020
Q2
$3.49M Sell
21,255
-1,896
-8% -$291K 1.08% 16
2020
Q1
$3.21M Sell
23,151
-6,559
-22% -$901K 1.14% 18
2019
Q4
$3.9M Buy
29,710
+1,002
+3% +$116K 1.08% 23
2019
Q3
$3.21M Sell
28,708
-462
-2% -$51.4K 1.03% 22
2019
Q2
$3.23M Sell
29,170
-1,254
-4% -$148K 0.95% 25
2019
Q1
$3.95M Sell
30,424
-673
-2% -$81.8K 1.19% 21
2018
Q4
$3.6M Sell
31,097
-6,375
-17% -$712K 1.1% 22
2018
Q3
$4.02M Buy
37,472
+676
+2% +$67.6K 0.89% 28
2018
Q2
$3.14M Buy
36,796
+1
+0% +$82 0.76% 36
2018
Q1
$2.85M Sell
36,795
-1,528
-4% -$123K 0.56% 49
2017
Q4
$3.24M Sell
38,323
-2
-0% -$170 0.77% 38
2017
Q3
$3.28M Sell
38,325
-604
-2% -$49.5K 0.8% 36
2017
Q2
$3.2M Sell
38,929
-7,330
-16% -$598K 0.68% 41
2017
Q1
$3.89M Sell
46,259
-213
-0.5% -$17.1K 0.89% 28
2016
Q4
$3.42M Buy
46,472
+3,802
+9% +$283K 0.73% 38
2016
Q3
$3.42M Buy
42,670
+14
+0% +$1.12K 0.82% 28
2016
Q2
$3.36M Sell
42,656
-373
-0.9% -$28.1K 0.81% 28
2016
Q1
$3.1M Sell
43,029
-699
-2% -$52.9K 0.77% 35
2015
Q4
$3.69M Sell
43,728
-399
-0.9% -$33.1K 0.88% 26
2015
Q3
$3.69M Buy
44,127
+350
+0.8% +$29.5K 0.96% 23
2015
Q2
$3.65M Sell
43,777
-2,474
-5% -$189K 0.94% 22
2015
Q1
$3.36M Sell
46,251
-3,123
-6% -$222K 0.86% 26
2014
Q4
$3.41M Buy
49,374
+680
+1% +$45.9K 0.89% 26
2014
Q3
$3.16M Sell
48,694
-744
-2% -$47.1K 0.94% 23
2014
Q2
$3.07M Sell
49,438
-2,148
-4% -$128K 0.92% 22
2014
Q1
$3.04M Buy
51,586
+566
+1% +$31.6K 0.99% 21
2013
Q4
$2.6M Sell
51,020
-1,293
-2% -$64.7K 0.88% 26
2013
Q3
$2.63K Buy
52,313
+1,316
+3% +$68.9K 0.83% 26
2013
Q2
$2.5M Buy
+50,997
New +$2.77M 0.88% 27

Other funds holding LLY

Essex Financial Services's LLY Position: Q1 2026 in Review

Essex Financial Services increased its Eli Lilly (LLY) stake by 0.03% in Q1 2026, buying an estimated $6.08K and bringing the position to 23,226 shares worth $21.4M. The position accounts for 1.2% of the portfolio, ranked #15.

Essex Financial Services first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $25M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Essex Financial Services held 23,226 shares of Eli Lilly worth $21.4M as of Q1 2026.
  • Essex Financial Services bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 1.2% of Essex Financial Services's portfolio in Q1 2026, its #15 holding.
  • Essex Financial Services first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's Eli Lilly position peaked at $25M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.